Medical Condition News

RSS

MGH investigators develop novel system to deliver growth factors to chronic wounds

Massachusetts General Hospital investigators have developed a novel system for delivery of growth factors to chronic wounds such as pressure sores and diabetic foot ulcers.

27 Jan 2011

Tryton initiates enrollment in Side Branch Stent System study

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the first U.S. patient has been enrolled in the pivotal trial to evaluate the Tryton Side Branch Stent System™ for the treatment of coronary artery disease.

27 Jan 2011

Researchers invent paper microfluidic device for rapid medical diagnostics, chemical analysis

Researchers have invented a technique that uses inexpensive paper to make "microfluidic" devices for rapid medical diagnostics and chemical analysis.

27 Jan 2011

Boston Scientific initiates enrollment in comparative Chinese study of PROMUS Element Everolimus-Eluting Stent

Boston Scientific Corporation today announced the beginning of patient enrollment in the PLATINUM China clinical trial, which is designed to evaluate the safety and effectiveness of the Company's PROMUS Element™ Everolimus-Eluting Platinum Chromium Coronary Stent compared to the TAXUS® Liberte® Paclitaxel-Eluting Coronary Stent in the treatment of patients with a single de novo atherosclerotic lesion.

27 Jan 2011

U.S. FDA announces link between breast implants and ALCL

The U.S. Food and Drug Administration today announced a possible association between saline and silicone gel-filled breast implants and anaplastic large cell lymphoma, a very rare type of cancer.

27 Jan 2011

Elimination of glucagon action may help convert Type 1 diabetes into non-insulin-dependent disorder

Type 1 diabetes could be converted to an asymptomatic, non-insulin-dependent disorder by eliminating the actions of a specific hormone, new findings by UT Southwestern Medical Center researchers suggest.

27 Jan 2011

War-time stress may lead to increased risk of death by coronary heart disease in later life

War-time stress may lead to an increased risk death by coronary heart disease in later life. Researchers writing in BioMed Central's open access journal BMC Health Services Research surveyed a cohort of 55 year old Finnish WW2 veterans in 1980, and then carried out a follow-up study 28 years later.

27 Jan 2011

Potential therapy to enhance memory and prevent loss of long-term memory

Researchers from Mount Sinai School of Medicine have identified a therapy that may enhance memory and prevent the loss of long-term memory. The research is published in the January 27th issue of Nature.

27 Jan 2011

Feeding regimens may improve respiratory health in premature babies with lung disease

Improving lung function in premature babies with a severe lung disease may be linked to their feeding regimen, according to a new University of Michigan study.

27 Jan 2011

Study: Low SES is linked to high risk of depression in patients with RA

Physical and Mental Health Disparities Found in Those with Low Socioeconomic Position. A recent study confirmed that low socioeconomic status is associated with higher risk of depressive symptoms in patients with rheumatoid arthritis.

26 Jan 2011

ChemoCentryx commences CCX832 Phase I trial in patients with psoriasis

ChemoCentryx, today announced the initiation of a Phase I clinical trial of CCX832, an orally-administered small molecule that is a potent and selective inhibitor of the chemoattractant receptor, ChemR23.

26 Jan 2011

Alcohol-related liver disease rising among young Britons

According to latest National Health Service (NHS) figures the number of people under 30 admitted to hospital in the past decade has risen by more than 50 per cent. 351 people aged 30 and under were admitted to an English hospital with alcohol related liver disease in 2009/10, up from 230 in 2000/01. That is still only a small fraction of the 14,500 people aged 31 or over who were admitted for alcohol-related liver problems in the last year.

26 Jan 2011

Spine surgeon successfully treated with RNL Bio's stem cell therapy for Autoimmune Arthritis

RNL BIO CO., LTD, a leading biopharmaceutical company specialized in adult stem cell therapeutics, announced on January 21, 2011 another successful patient report utilizing stem cell therapy on a leading US orthopedic spine surgeon who suffered from Autoimmune Arthritis.

26 Jan 2011

Pill for multiple sclerosis in the pipeline

Multiple Sclerosis or MS is a severely disabling disease that affects 100,000 in the UK. Now a new pill has been developed to treat multiple sclerosis which means there would be no need for injections. European health experts - European Medicines Agency (EMA) have given the new drug Gilenya, the brand name for the drug fingolimod, approval which would grant it EU wide acceptance.

25 Jan 2011

Survival following transplant surgery for liver cancer not impacted by HIV-positive status

French researchers determined that infection with human immunodeficiency virus (HIV) impaired results of transplant surgery for liver cancer, with more HIV infected patients dropping off the transplantation wait list. The team found that overall survival and recurrence-free survival was not impacted following liver transplantation in patients with controlled HIV disease.

25 Jan 2011

Evaluating patients for genetic variations impacts adherence to antiviral therapy

In two recent studies, researchers have identified two functional variants in the inosine triphosphatase (ITPA) gene that protect patients with hepatitis C virus (HCV) against anemia brought on by antiviral treatment. The ability to identify those patients protected against treatment-induced anemia will ensure completion of antiviral therapy and successful elimination of the virus.

25 Jan 2011

FDA grants BioSante Orphan Drug designation for Melanoma Cancer Vaccine

BioSante Pharmaceuticals, Inc. today announced the receipt of Orphan Drug designation for its Melanoma Cancer Vaccine in the treatment of stage IIb to IV melanoma, from the FDA's Office of Orphan Products Development. Melanoma is the most deadly form of skin cancer.

25 Jan 2011

Emergent BioSolutions initiates TRU-016 Phase Ib/II study for chronic lymphocytic leukemia

Emergent BioSolutions Inc. today announced the initiation of a Phase Ib/II study (16201) of TRU-016 for chronic lymphocytic leukemia (CLL). TRU-016 is a CD37-directed Small Modular ImmunoPharmaceutical (SMIP™) protein therapeutic in development for the treatment of B-cell malignancies. TRU-016 is being developed in collaboration with Abbott.

25 Jan 2011

Majority of the public favor physician-assisted suicide for terminally ill patients in great pain

A new Harris/BBC World News America poll finds that large majorities of Americans now favor physician assisted suicide and euthanasia for terminally ill patients in great pain who wish to end their lives. It also finds that a majority of people over 65 now have written directives regarding the type of care they would like to receive, or not to receive, at the end stages of their lives.

25 Jan 2011

Massive drinks mean massive calories

When you're ordering the new Starbucks "trenta" you're not only getting a massive drink (31 ounces) but massive calories (up to 600) - with the potential to pack on more than 60 extra pounds in one year.

25 Jan 2011

Medical Condition News

MGH investigators develop novel system to deliver growth factors to chronic wounds

Tryton initiates enrollment in Side Branch Stent System study

Researchers invent paper microfluidic device for rapid medical diagnostics, chemical analysis

Boston Scientific initiates enrollment in comparative Chinese study of PROMUS Element Everolimus-Eluting Stent

U.S. FDA announces link between breast implants and ALCL

Elimination of glucagon action may help convert Type 1 diabetes into non-insulin-dependent disorder

War-time stress may lead to increased risk of death by coronary heart disease in later life

Potential therapy to enhance memory and prevent loss of long-term memory

Feeding regimens may improve respiratory health in premature babies with lung disease

Study: Low SES is linked to high risk of depression in patients with RA

ChemoCentryx commences CCX832 Phase I trial in patients with psoriasis

Alcohol-related liver disease rising among young Britons

Spine surgeon successfully treated with RNL Bio's stem cell therapy for Autoimmune Arthritis

Pill for multiple sclerosis in the pipeline

Survival following transplant surgery for liver cancer not impacted by HIV-positive status

Evaluating patients for genetic variations impacts adherence to antiviral therapy

FDA grants BioSante Orphan Drug designation for Melanoma Cancer Vaccine

Emergent BioSolutions initiates TRU-016 Phase Ib/II study for chronic lymphocytic leukemia

Majority of the public favor physician-assisted suicide for terminally ill patients in great pain

Massive drinks mean massive calories

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Latest News